VRDN icon

Viridian Therapeutics

39 hedge funds and large institutions have $223M invested in Viridian Therapeutics in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
39
Holders Change
+13
Holders Change %
+50%
% of All Funds
0.68%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
16
Increased
16
Reduced
3
Closed
3
Calls
$926K
Puts
Net Calls
+$926K
Net Calls Change
+$926K
Name Holding Trade Value Shares
Change
Shares
Change %
DCM
26
Driehaus Capital Management
Illinois
$823K +$823K +50,000 New
SSA
27
Schonfeld Strategic Advisors
New York
$724K +$724K +44,000 New
Northern Trust
28
Northern Trust
Illinois
$570K +$52.4K +3,184 +10%
LP
29
LMR Partners
United Kingdom
$551K +$551K +33,508 New
State Street
30
State Street
Massachusetts
$392K +$210K +12,800 +116%
VA
31
VR Adviser
New York
$321K
Morgan Stanley
32
Morgan Stanley
New York
$163K +$48.2K +2,937 +42%
Walleye Trading
33
Walleye Trading
New York
$123K +$123K +7,500 New
UBS Group
34
UBS Group
Switzerland
$24K +$23.8K +1,430 +11,000%
RCM
35
RA Capital Management
Massachusetts
$17K -$5.12M -311,294 -100%
Wells Fargo
36
Wells Fargo
California
$7K -$1.82K -107 -21%
Bank of America
37
Bank of America
North Carolina
$3K +$3K +173 New
Walleye Capital
38
Walleye Capital
New York
$370 +$370 +22,501 New
Wellington Management Group
39
Wellington Management Group
Massachusetts
-$10.6M -578,560 Closed
Balyasny Asset Management
40
Balyasny Asset Management
Illinois
-$2.19M -119,478 Closed
B
41
Bailard
California
-$1.66M -90,500 Closed